CTOs on the Move

Smile Virtual

www.smilevirtual.com

 
Smile Virtual is an online dental consultation platform that connects patients with dentists for virtual consultations to learn about treatment options for improving their smile without leaving home.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

YMCA of Central New York

At the Y, our cause is strengthening the foundations of community.

Howard Center

Situated alongside Lake Champlain, we are the largest private non-profit human services organization in the State of Vermont. Since 1865, Howard Center has been helping people and communities thrive by providing supports and services to address mental health, substance use, and developmental needs. Today, we employ 1,600 staff providing services in 60 locations serving more than 16,000 community members annually. Through our competitive and award-winning benefits, work-life balance and equal opportunity employment, we build teams of dedicated, passionate individuals who embrace our mission and are committed to making a lasting contribution to the lives of the people we serve. The world around us continues to change every day. At Howard Center, we believe it is vital to face new and unanticipated obstacles with all of our voices. We welcome applicants of all racial and ethnic backgrounds, identities and expressions, religious beliefs, disabilities, age groups, lived experiences and perspectives. In order to provide the best care for our clients, our aim is for our staff to be a reflection of the community we serve.

Harmonize

A remote care platform to impact patients at scale

Burke Williams

Burke Williams is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cellenkos Incorporated

Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.